April 12, 2021 Advanced radiotherapy ‘must play central role’ in clearing Covid’s cancer backlog Urgent investment is needed in advanced forms of radiotherapy so the high-tech treatment can play a central role in clearing the backlog in NHS cancer care that has built up during the pandemic. Leading cancer experts are calling for the Government to address gaps in funding for high-precision radiotherapy and to do more to overcome […]
March 16, 2021 Six Imperial researchers awarded leading health honours Six Imperial researchers have been appointed to prestigious research positions by the National Institute of Health Research (NIHR). They have been named as NIHR Senior Investigators – positions given to those who are deemed to be the most outstanding leaders of patient and people-based research within the NIHR faculty. They provide research leadership to the NIHR […]
November 13, 2020 Cancer patients at increased risk of severe outcomes from COVID-19 Patients with cancer have a much higher risk of severe outcomes and death from COVID-19 than non-cancer patients. In an analysis of 15 research studies involving more than 3,000 patients around the world, researchers found that cancer patients who contracted COVID-19 had a 23 per cent risk of mortality compared to non-cancer patients with COVID […]
November 10, 2020 New Unit to advance cancer prevention research and strategies A new Unit focusing on cancer prevention research and strategies has launched at Imperial and The Institute of Cancer Research, London. The Cancer Epidemiology and Prevention Unit (CEPRU) is a joint initiative between Imperial College London and The Institute of Cancer Research. Its vision is to be a global leader in advancing research on the […]